Cytokinetics

$24.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.12%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Cytokinetics and other stocks, options, and ETFs commission-free!

About CYTK

Cytokinetics, Inc. operates as a biopharmaceutical company. The firm focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases.

CEO
Robert I. Blum
Employees
184
Headquarters
South San Francisco, California
Founded
1997
Market Cap
1.72B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
683.63K
High Today
$24.51
Low Today
$23.54
Open Price
$24.00
Volume
598.04K
52 Week High
$30.14
52 Week Low
$13.08

CYTK Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

ONEY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure